These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33272981)

  • 1. A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
    Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF
    Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.
    Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T
    Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls in RET Fusion Detection Using Break-Apart FISH Probes in Papillary Thyroid Carcinoma.
    Liu Y; Wu S; Zhou L; Guo Y; Zeng X
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1129-1138. PubMed ID: 33382428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma.
    Go H; Jung YJ; Kang HW; Park IK; Kang CH; Lee JW; Ju YS; Seo JS; Chung DH; Kim YT
    Lung Cancer; 2013 Oct; 82(1):44-50. PubMed ID: 23932363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating
    Rich TA; Reckamp KL; Chae YK; Doebele RC; Iams WT; Oh M; Raymond VM; Lanman RB; Riess JW; Stinchcombe TE; Subbiah V; Trevarthen DR; Fairclough S; Yen J; Gautschi O
    Clin Cancer Res; 2019 Oct; 25(19):5832-5842. PubMed ID: 31300450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic characteristics and diagnostic methods of
    Feng J; Li Y; Wei B; Guo L; Li W; Xia Q; Zhao C; Zheng J; Zhao J; Sun R; Guo Y; Brcic L; Hakozaki T; Ying J; Ma J
    Transl Lung Cancer Res; 2022 Apr; 11(4):617-631. PubMed ID: 35529790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
    Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
    Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.
    Zhang T; Lu Y; Ye Q; Zhang M; Zheng L; Yin X; Gavine P; Sun Z; Ji Q; Zhu G; Su X
    Genes Chromosomes Cancer; 2015 Mar; 54(3):168-76. PubMed ID: 25407564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients.
    Kim JO; Shin JY; Kim MY; Son KH; Jung CK; Kim TJ; Kim SY; Park JK; Sung SW; Bae SJ; Min HJ; Kang JH
    Surg Oncol; 2018 Mar; 27(1):106-113. PubMed ID: 29549897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions.
    Antonescu CR; Dickson BC; Swanson D; Zhang L; Sung YS; Kao YC; Chang WC; Ran L; Pappo A; Bahrami A; Chi P; Fletcher CD
    Am J Surg Pathol; 2019 Oct; 43(10):1384-1391. PubMed ID: 31219820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer.
    Radonic T; Geurts-Giele WRR; Samsom KG; Roemen GMJM; von der Thüsen JH; Thunnissen E; Meijssen IC; Sleddens HFBM; Dinjens WNM; Boelens MC; Weijers K; Speel EJM; Finn SP; O'Brien C; van Wezel T; Cohen D; Monkhorst K; Roepman P; Dubbink HJ
    J Thorac Oncol; 2021 May; 16(5):798-806. PubMed ID: 33588111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
    Su YJ; Lee YH; Jin YT; Hsieh MS
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization.
    Krystel-Whittemore M; Taylor MS; Rivera M; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Deshpande V; Chebib I; Nielsen GP; Wu CL; Nardi V
    Hum Pathol; 2019 Nov; 93():65-73. PubMed ID: 31430493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary Thyroid Cancer.
    Wu S; Liu Y; Li K; Liang Z; Zeng X
    J Mol Diagn; 2023 Aug; 25(8):569-582. PubMed ID: 37236546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.
    Nagasaka M; Brazel D; Baca Y; Xiu J; Al-Hallak MN; Kim C; Nieva J; Swensen JJ; Spetzler D; Korn WM; Socinski MA; Raez LE; Halmos B; Ou SI
    Transl Oncol; 2023 Oct; 36():101744. PubMed ID: 37516008
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.
    Li W; Guo L; Liu Y; Dong L; Yang L; Chen L; Liu K; Shao Y; Ying J
    J Thorac Oncol; 2021 Mar; 16(3):404-418. PubMed ID: 33248323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
    Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
    J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study.
    Shen T; Pu X; Wang L; Yu Z; Li J; Zhang Y; Liang X; Chen H; Xu C; Song Z; Wang W
    Clin Lung Cancer; 2020 Sep; 21(5):e349-e354. PubMed ID: 32143967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.